Surgery Doctors in Orange, CA Accepting Medicare
107 Surgery doctors found. Showing 101 - 107
 Dr. Nii-kabu Kabutey, MD Surgery - Vascular Surgery Medicare: Accepting Medicare Assignments Practice Location: 333 City Blvd W, Suite 1600, Orange, CA 92868 Phone: 714-456-5453 Fax: 714-456-6070 |
 Christina Boyd, M.D Surgery Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 714-456-6595 |
Dr. Veeshal H Patel, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 714-456-8888 |
Timothy Harward, M.D. Surgery - Vascular Surgery Medicare: Medicare Enrolled Practice Location: 1140 W La Veta Ave, Ste. 850, Orange, CA 92868 Phone: 714-560-4450 Fax: 714-560-4455 |
Skandan Shanmugan, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 714-456-8888 Fax: 714-509-2257 |
Dr. Shawndeep S Tung, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 230 S Main St Ste 100, Orange, CA 92868 Phone: 714-541-0101 Fax: 714-541-0450 |
Dr. Milton Leroy Owens, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2617 E Chapman Ave, Suite 307, Orange, CA 92869 Phone: 714-997-4448 Fax: 714-997-4449 |
News Archive
FluCide nanoviricide drug reduces overall leukocytes in lung tissue of influenza model
NanoViricides, Inc. reports that post-infection treatment with its optimized FluCide drug candidates resulted in significant reduction in lung tissue presence of leukocytes, and in particular, that of eosinophils in a lethal influenza infection animal model.
Invivo recognized with 2010 Gold Medical Design Excellence Award
On June 9, 2010, Invivo was recognized with a 2010 Gold Medical Design Excellence Award for its DynaCAD for Prostate and DynaTRIM (Trans-Rectal Interventional MRI) clinical solutions. The MDEA awards ceremony took place in early June at New York City's Jacob K. Javits Convention Center where gold and silver winners were honored.
Genetic variation associated with MUC5B gene may increase risk of developing Pulmonary Fibrosis
A new discovery in a deadly lung disease may change the direction of research while uncovering increased risk for many patients and families. The Coalition for Pulmonary Fibrosis (CPF) and the Pulmonary Fibrosis Foundation (PFF) applaud the efforts of scientists that led to the discovery of a genetic variation associated with the MUC5B gene which may increase the risk of developing Pulmonary Fibrosis (PF).
Targacept, AstraZeneca expand TC-5619 development program to include ADHD, Alzheimer's disease
Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced an amendment to its 2005 collaboration agreement with AstraZeneca expanding the TC-5619 development program. In addition to the current development of TC-5619 in cognitive dysfunction in schizophrenia (CDS), the amended terms provide for parallel development in attention deficit/hyperactivity disorder (ADHD) and potentially Alzheimer's disease.
Seeds of violence may be planted before a child is born: Research
It's hard to think of a baby being violent or destructive, but the seeds of violence may be planted before a child is born, according to research at the University of Pennsylvania School of Nursing.
› Verified 3 days ago
Internal Medicine
Pediatrics
Anesthesiology
Psychiatry & Neurology
Radiology
Emergency Medicine
Family Medicine
Surgery
Obstetrics & Gynecology
Orthopaedic Surgery